C93H96F2N30O13S — CID 158166230
N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]cyclopropanecarboxamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]-3-fluorobenzamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]furan-2-carboxamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]-2-methylsulfanylbenzamide;3-fluoro-N-[5-methyl-2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)pyrazol-3-yl]benzamide;N-[5-methyl-2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)pyrazol-3-yl]cyclopropanecarboxamide (PubChem CID 158166230) has the molecular formula C93H96F2N30O13S and a molecular weight of 1912.05 g/mol. Its IUPAC name is N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]cyclopropanecarboxamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]-3-fluorobenzamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]furan-2-carboxamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]-2-methylsulfanylbenzamide;3-fluoro-N-[5-methyl-2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)pyrazol-3-yl]benzamide;N-[5-methyl-2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)pyrazol-3-yl]cyclopropanecarboxamide.
| Compound Name | N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]cyclopropanecarboxamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]-3-fluorobenzamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]furan-2-carboxamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]-2-methylsulfanylbenzamide;3-fluoro-N-[5-methyl-2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)pyrazol-3-yl]benzamide;N-[5-methyl-2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)pyrazol-3-yl]cyclopropanecarboxamide |
|---|---|
| PubChem CID | 158166230 |
| Molecular Formula | C93H96F2N30O13S |
| Molecular Weight | 1912.05 g/mol |
| Exact Mass | 1910.75 |
| IUPAC Name | N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]cyclopropanecarboxamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]-3-fluorobenzamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]furan-2-carboxamide;N-[2-(4-ethyl-6-oxo-1H-pyrimidin-2-yl)-5-methylpyrazol-3-yl]-2-methylsulfanylbenzamide;3-fluoro-N-[5-methyl-2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)pyrazol-3-yl]benzamide;N-[5-methyl-2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)pyrazol-3-yl]cyclopropanecarboxamide |
| SMILES | CCc1cc(=O)[nH]c(-n2nc(C)cc2NC(=O)C2CC2)n1.CCc1cc(=O)[nH]c(-n2nc(C)cc2NC(=O)c2cccc(F)c2)n1.CCc1cc(=O)[nH]c(-n2nc(C)cc2NC(=O)c2ccccc2SC)n1.CCc1cc(=O)[nH]c(-n2nc(C)cc2NC(=O)c2ccco2)n1.Cc1cc(=O)[nH]c(-n2nc(C)cc2NC(=O)C2CC2)n1.Cc1cc(=O)[nH]c(-n2nc(C)cc2NC(=O)c2cccc(F)c2)n1 |
| InChI | InChI=1S/C18H19N5O2S.C17H16FN5O2.C16H14FN5O2.C15H15N5O3.C14H17N5O2.C13H15N5O2/c1-4-12-10-16(24)21-18(19-12)23-15(9-11(2)22-23)20-17(25)13-7-5-6-8-14(13)26-3;1-3-13-9-15(24)21-17(19-13)23-14(7-10(2)22-23)20-16(25)11-5-4-6-12(18)8-11;1-9-7-14(23)20-16(18-9)22-13(6-10(2)21-22)19-15(24)11-4-3-5-12(17)8-11;1-3-10-8-13(21)18-15(16-10)20-12(7-9(2)19-20)17-14(22)11-5-4-6-23-11;1-3-10-7-12(20)17-14(15-10)19-11(6-8(2)18-19)16-13(21)9-4-5-9;1-7-6-11(19)16-13(14-7)18-10(5-8(2)17-18)15-12(20)9-3-4-9/h5-10H,4H2,1-3H3,(H,20,25)(H,19,21,24);4-9H,3H2,1-2H3,(H,20,25)(H,19,21,24);3-8H,1-2H3,(H,19,24)(H,18,20,23);4-8H,3H2,1-2H3,(H,17,22)(H,16,18,21);6-7,9H,3-5H2,1-2H3,(H,16,21)(H,15,17,20);5-6,9H,3-4H2,1-2H3,(H,15,20)(H,14,16,19) |
| InChIKey | FWWJMAPMCVVVLN-UHFFFAOYSA-N |
| XLogP | 10.75 |
| TPSA | 569.16 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 139 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1912.05 |
| LogP ≤ 5 | 10.75 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 32 |